Generic medicines as a way to improve access and affordability: A proposed framework for Pakistan

Journal of Clinical and Diagnostic Research

Volumn 3, Issue 3, 2009, Pages 1596-1600

  Jamshed, Shazia Qasim ^a   Babar, Z U D ^b   Ibrahim, M I M ^c   Hassali, M A A ^c  

^a SCHOOL OF PHYSICS   (Malaysia)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

Author keywords

Drug policy; Generic medicines; Pakistan; Pharmaceutical industry

Indexed keywords

ANTIRETROVIRUS AGENT; GENERIC DRUG;

CONSUMER; COST CONTROL; DEVELOPING COUNTRY; DRUG COST; DRUG INDUSTRY; DRUG MARKETING; DRUG QUALITY; FOOD AND DRUG ADMINISTRATION; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH PERSONNEL ATTITUDE; HUMAN; PAKISTAN; PATENT; PRESCRIPTION; REVIEW; SOCIOECONOMICS;

EID: 67650151406     PISSN: None     EISSN: 0973709X     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. The World Medicines Situation (2004). World Health Organization, WHO/EDM/ PAR/2004.5
2. Birkett DJ. Generics Equal or not? Australian Prescriber. 2003; 26, 85-87.
3. World Health Organization. Globalization, Trade and Health, http://www.who.int/trade/glossary/story034/en/index.html, Accessed 10th November 2007.
4. Center for Drug Evaluation and Research. 2004. Report to the Nation 2003. Rockville, MD: FDA
5. WHO Medicines Strategy Countries at the Core 2004-2007, http://whqlibdoc.who.int/hq/2004/WHO_EDM_2004.2.pdf, Accessed 25th November 2007.
6. Biga J, Taboulet F, Lapeyre-Mestre M, Duguet, A.M., Vincent, S., Montastruc, J. L. Prescribing drugs by international non-proprietary name: the perception of health and non-health professionals. Therapie. 2005; 60: 401-7.
7. Lagarce L, Lusson-Brisset C, Bruhat C, Diquet, B., Lainé-Cessac, P. How practitioners view generic drugs: an opinion study from general practitioners in Maine-et-Loire (France). Therapie. 2005; 60: 67-74
8. Bertoldi AD, Barros AJ, Hallal PC Generic drugs in Brazil: known by many, used by few. Cad Saude publica. 2005; 21: 1808-15.
9. Kersnik J. Peklar J. Attitudes of Slovene general practitioners towards generic drug prescribing and comparison with international studies. J Clin Pharm Ther. 2006; 31: 577-83.
10. Hassali MA., Kong DCM. Stewart, K. Utilisation of generic medicines in the Australian healthcare system. Journal of Generic Medicines. 2004; 2: 42-52.
11. King DR & Kanavos P. Encouraging the Use of Generic Medicines: Implications for Transition Economies. CMJ.2002; 43: 462-69.
12. Tempest B. India: A global strategic asset for developed world market businesses. Journal of Generic Medicines 2006; 4: 37-42
13. Pakistan factsheet. http://www.dfid.gov.uk/countries/asia/pakistan.asp. Accessed 10th November 2007.
14. Economic survey of Pakistan, 2003-2004. Islamabad: Government of Pakistan, Finance Division, Economic Advisers Wing; 2004.
15. Pakistan Demographic Survey 2003, Accessed http://www.statpak.gov.pk/ depts/fbs/statistics/pds2003/pds2003.html
16. IMS health, http://www.imshealth.com/web/channel/ 0,3147,64639575_63872702_76856130,00.html Accessed 10th November 2007
17. Drug Control Organization, Ministry of Health, Government of Pakistan (2005), http://www.dcomoh.gov.pk/ Accessed 10th November 2007
18. Syed R (2007). Pharma exports to touch $600m by 2010: exporters. June 2007. Available at http://www.dailytimes.com.pk/ default.asp?page=2007%5C06%5C30%5Cstory_30-6-2007_pg5_2. (Accessed on 09/ 02/08).
19. A Govt plans incentives for Pharmaceutical industry. 06/01/2008 Available at http://www.khaleejtimes.com/ DisplayArticleNew.asp?xfile=data/business/2008/January/ business_January126.xml§ion=business&col= (Accessed on 10/02/ 2008).
20. Government wants sale of drugs under generic names, http://www.dawn.com/ 2007/10/25/local17.htm, Accessed 25th November 2007.
21. Centre urged to lower prices of drugs. http://www.dawn.com/2007/09/30/ local7.htm, Accessed 25th November 2007.
22. Quraeshi ZA, Luqmani M, Malhotra N. Brands or generics: the dilemma of pharmaceutical marketing in a developing country. J Health Care Mark.1983; 3: 27-37.
23. Obaid R, Obaid A, Saify Z S, Kamil N, Khan M H, Ahmed T, Ahmed S W. Pharmacokinetic differences of some generic tablet Gliclazide 80 mg on Pakistani population. Pak J Pharm Sci. 2004; 17: 55-64.
24. Kiani A, Qadeer A, Mirza Z, Khanum A, Tisocki K, Mustafa T Prices, availability and affordability of Medicines in Pakistan. Report of The Network for Consumer Protection, www.haiweb.org/medicineprices/surveys/ 200407PK/survey_report.pdf Accessed 25th November 2007.
25. www.dfidhealthrc.org/MeTA/documents/17%20april%20documents/ Country%20Profile-Pakistan.doc (Accessed on 10/20/2008)
26. Doha Declaration on TRIPS and Public Health, signed at WTO Ministerial meeting in Doha, Qatar on 14 November 2001